Safiri S, Ghaffari Jolfayi A, Fazlollahi A, Morsali S, Sarkesh A, Daei Sorkhabi A
Front Med (Lausanne). 2024; 11:1474043.
PMID: 39736972
PMC: 11682909.
DOI: 10.3389/fmed.2024.1474043.
Mei T, Chen Y, Gao Y, Zhao H, Lyu X, Lin J
NPJ Microgravity. 2024; 10(1):100.
PMID: 39468074
PMC: 11519943.
DOI: 10.1038/s41526-024-00441-0.
Shi G, Wu T, Li X, Zhao D, Yin Q, Zhu L
Front Neurosci. 2024; 18:1385675.
PMID: 38765669
PMC: 11099245.
DOI: 10.3389/fnins.2024.1385675.
Gomes B, Peixinho N, Pisco R, Gromicho M, Pronto-Laborinho A, Rueff J
Mol Neurobiol. 2023; 60(12):7104-7117.
PMID: 37531027
PMC: 10657797.
DOI: 10.1007/s12035-023-03520-7.
Mohamadzadeh O, Hajinouri M, Moammer F, Tamehri Zadeh S, Omid Shafiei G, Jafari A
Mol Neurobiol. 2023; 60(7):4064-4083.
PMID: 37020123
DOI: 10.1007/s12035-023-03321-y.
Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson's disease.
Soto M, Fernandez M, Bravo P, Lahoz S, Garrido A, Sanchez-Rodriguez A
NPJ Parkinsons Dis. 2023; 9(1):15.
PMID: 36732514
PMC: 9894906.
DOI: 10.1038/s41531-023-00451-x.
Role and Dysregulation of miRNA in Patients with Parkinson's Disease.
Salemi M, Marchese G, Lanza G, Cosentino F, Salluzzo M, Schillaci F
Int J Mol Sci. 2023; 24(1).
PMID: 36614153
PMC: 9820759.
DOI: 10.3390/ijms24010712.
Identifying Key MicroRNA Signatures for Neurodegenerative Diseases With Machine Learning Methods.
Li Z, Guo W, Ding S, Chen L, Feng K, Huang T
Front Genet. 2022; 13:880997.
PMID: 35528544
PMC: 9068882.
DOI: 10.3389/fgene.2022.880997.
Exosomes Mediate APP Dysregulation APP-miR-185-5p Axis.
Ding L, Yang X, Xia X, Li Y, Wang Y, Li C
Front Cell Dev Biol. 2022; 10:793388.
PMID: 35223832
PMC: 8873530.
DOI: 10.3389/fcell.2022.793388.
RNA Dynamics in Alzheimer's Disease.
Rybak-Wolf A, Plass M
Molecules. 2021; 26(17).
PMID: 34500547
PMC: 8433936.
DOI: 10.3390/molecules26175113.
Personalized Healthcare for Dementia.
Lee S, Cho E, Kwak H
Healthcare (Basel). 2021; 9(2).
PMID: 33525656
PMC: 7910906.
DOI: 10.3390/healthcare9020128.
Urinary Biomarkers for Neurodegenerative Diseases.
Seol W, Kim H, Son I
Exp Neurobiol. 2020; 29(5):325-333.
PMID: 33154195
PMC: 7649089.
DOI: 10.5607/en20042.
Biochemical Parameters in Cognitive Functions.
Popiolek A, Chyrek-Tomaszewska A, Stachowicz-Karpinska A, Bielinski M, Borkowska A
Neuropsychiatr Dis Treat. 2020; 16:2479-2489.
PMID: 33149589
PMC: 7602911.
DOI: 10.2147/NDT.S267673.
Circulating Inflammatory miRNAs Associated with Parkinson's Disease Pathophysiology.
Oliveira S, Dionisio P, Guedes L, Goncalves N, Coelho M, Rosa M
Biomolecules. 2020; 10(6).
PMID: 32585840
PMC: 7356527.
DOI: 10.3390/biom10060945.
Alteration of functional connectivity in patients with Alzheimer's disease revealed by resting-state functional magnetic resonance imaging.
Zhao J, Du Y, Ding X, Wang X, Men G
Neural Regen Res. 2019; 15(2):285-292.
PMID: 31552901
PMC: 6905343.
DOI: 10.4103/1673-5374.265566.
Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents.
Xia X, Wang Y, Huang Y, Zhang H, Lu H, Zheng J
Prog Neurobiol. 2019; 183:101694.
PMID: 31542363
PMC: 7323939.
DOI: 10.1016/j.pneurobio.2019.101694.
Glutaminase C Regulates Microglial Activation and Pro-inflammatory Exosome Release: Relevance to the Pathogenesis of Alzheimer's Disease.
Gao G, Zhao S, Xia X, Li C, Li C, Ji C
Front Cell Neurosci. 2019; 13:264.
PMID: 31316350
PMC: 6611423.
DOI: 10.3389/fncel.2019.00264.
Does SCFD1 rs10139154 Polymorphism Decrease Alzheimer's Disease Risk?.
Stamati P, Siokas V, Aloizou A, Karampinis E, Arseniou S, Rakitskii V
J Mol Neurosci. 2019; 69(2):343-350.
PMID: 31267315
DOI: 10.1007/s12031-019-01363-3.
MicroRNAs in Alzheimer's Disease.
Wang M, Qin L, Tang B
Front Genet. 2019; 10:153.
PMID: 30881384
PMC: 6405631.
DOI: 10.3389/fgene.2019.00153.
Wide Profiling of Circulating MicroRNAs in Spinocerebellar Ataxia Type 7.
Borgonio-Cuadra V, Valdez-Vargas C, Romero-Cordoba S, Hidalgo-Miranda A, Tapia-Guerrero Y, Cerecedo-Zapata C
Mol Neurobiol. 2019; 56(9):6106-6120.
PMID: 30721448
DOI: 10.1007/s12035-019-1480-y.